HEMP EXTRACT FOR TREATMENT OF PAIN IN ANIMALS

1 . A pharmaceutical composition comprising hemp extract and a carrier, wherein the hemp extract comprises:

cannabidiol; and

cannabidiolic acid;

wherein the ratio of cannabidiol to cannabidiolic acid is about 0.6:1 to about 1:0.6.

2 . The pharmaceutical composition of claim 1 , where in hemp extract further comprises:

cannabigerolic acid;

D9-tetrahydrocannabinol; and

cannabichromene.

3 . The pharmaceutical composition of claim 1 , wherein the hemp extract further comprises four or more of the following:

α-pinene;

β-myrcene;

β-pinene;

δ-limonene;

linalool;

β-caryophyllene;

α-humulene;

nerolidol 2;

guaiol;

caryophyllene oxide; and

α-bisabolol.

4 - 17 . (canceled)

18 . The pharmaceutical composition of claim 1 , wherein the composition is formulated in a carrier.

19 . The pharmaceutical composition of claim 18 , wherein the carrier is selected from the group consisting of linseed oil, olive oil, fish oil, salmon oil, coconut oil, catnip oil, sesame oil, and grapeseed oil.

20 . The pharmaceutical composition of claim 19 , wherein the carrier is grapeseed oil.

21 . The pharmaceutical composition of claim 19 , wherein the carrier is catnip oil.

22 - 27 . (canceled)

28 . The pharmaceutical composition of claim 1 , wherein the composition is formulated as a chew for oral administration.

29 - 32 . (canceled)

33 . A pharmaceutical composition comprising hemp extract and a carrier, wherein the hemp extract comprises four or more of:

α-pinene;

β-myrcene;

β-pinene;

δ-limonene;

linalool;

β-caryophyllene;

α-humulene;

nerolidol 2;

guaiol;

caryophyllene oxide; and

α-bisabolol.

34 - 46 . (canceled)

47 . The pharmaceutical composition of claim 33 wherein the pharmaceutical composition is formulated as a chew for oral administration.

48 - 73 . (canceled)

74 . A dosage form comprising the pharmaceutical composition of claim 1 and one or more pharmaceutically acceptable additives, flavoring agents, surfactants, and adjuvants.

75 - 113 . (canceled)

114 . A dosage form comprising:

glucosamine HCl;

chondroitin sulfate (76%) or hyaluronic acid;

brewer's yeast;

arabic gum;

guar gum;

a flavoring agent;

hemp extract;

glycerin;

sunflower lecithin; and

water.

115 - 119 . (canceled)

120 . A dosage form comprising:

hemp extract;

peanut butter;

rice bran;

glucosamine HCl;

sweet potato;

dry molasses;

sorbic acid

brewer's yeast;

sugar;

water;

glycerin;

potato starch;

dehydrated peanut butter;

rice starch; and

guar gum.

121 - 131 . (canceled)

132 . A method for treating or reducing pain in a veterinary subject in need thereof, comprising administering to the subject a therapeutically effective amount of the pharmaceutical composition of claim 1 .

133 - 150 . (canceled)

151 . A method for treating or reducing pain associated with arthritis, post-operative pain, acute pain, dental pain, pain associated with gingivitis, or multi joint pain in a veterinary subject in need thereof, comprising administering to the subject a therapeutically effective amount of hemp extract.

152 - 165 . (canceled)

166 . A method of achieving an area under the curve from 0 time to 24 hours of between 42.4 and 3048 ng hr/ml for cannabidiol in a veterinary subject comprising administering to the subject an effective amount of hemp extract.

167 . (canceled)

168 . The pharmaceutical composition of claim 1 , wherein the hemp extract does not comprise terpenes.

169 . A dosage form comprising the pharmaceutical composition of claim 33 and one or more pharmaceutically acceptable additives, flavoring agents, surfactants, and adjuvants.

170 . A method for treating or reducing pain in a veterinary subject in need thereof, comprising administering to the subject a therapeutically effective amount of the pharmaceutical composition of claim 33 .

171 . A method for treating or reducing pain in a veterinary subject in need thereof, comprising administering to the subject a therapeutically effective amount of the dosage form of claim 74 .

172 . A method for treating or reducing pain in a veterinary subject in need thereof, comprising administering to the subject a therapeutically effective amount of the dosage form of claim 114 .

173 . A method for treating or reducing pain in a veterinary subject in need thereof, comprising administering to the subject a therapeutically effective amount of the dosage form of claim 117 .

174 . A method for treating or reducing pain in a veterinary subject in need thereof, comprising administering to the subject a therapeutically effective amount of the dosage form of claim 120 .